Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients

Schizophrenia Clinical Trial

Official title:

Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00780884
• Other study ID #: 0015-08
• Status: Completed
• Phase: N/A
• First received: October 26, 2008
• Last updated: June 21, 2015
• Start date: April 2008
• Est. completion date: April 2009

Study information

• Verified date: June 2015
• Source: HaEmek Medical Center, Israel
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

Insomnia, a common feature of schizophrenia, has serious consequences for daytime functioning and quality of life. Although insomnia is most often treated with medication, a growing number of studies have demonstrated the efficiency of a variety of relaxation techniques, cognitive behavioral therapies and alternative medicine procedures. Acupuncture is among the oldest healing practices in the world. Part of traditional Chinese medicine, acupuncture aims to restore and maintain health through the stimulation of specific points on the body. Previous studies have demonstrated that acupuncture has a positive influence on a number of diseases and disorders, among them Depression, Chronic Pain and Sleep Disorders. Hence, the aim of the present study is to examine the effects of acupuncture as a treatment for insomnia in schizophrenic patients.The study begins with a 7-day, running-in, no-treatment period, followes by an 8-week experimental period. During the experimental period, subjects receive acupuncture treatments twice a week. During the first week of the study (no-treatment period) and the last week of the experimental period, subjects' sleep is monitored with a wrist actigraph, and subjects complete a wide spectrum of questionnaires.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: April 2009
• Est. primary completion date: April 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. schizophrenia or schizoaffective disorder - diagnosed according DSM-4.

2. capability to sign inform consent.

Exclusion Criteria:

1. unstable physical illness

2. drug or alchohol abuse or dependence

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Schizoaffective
• Schizophrenia

Intervention

Device:
• acupuncture
16 sessions of acupuncture treatment, twice a week.

Locations

Country	Name	City	State
Israel	Haemek Medical Center	Afula

Sponsors (1)

Lead Sponsor	Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	sleep efficiency		8 weeks	No
Secondary	anxiety and depression levels		8 weeks	No